Small Molecules

Lawsuit from GenBioPro is the first of its kind – but other cases are likely to follow.

Water is the giver of life, but could it be a giver of untold medicines too?

Though key hurdles remain, there is huge potential for mRNA-based therapeutics to tackle areas of unmet need.

BASF has put substantial effort into reducing carbon emissions. A key aspect of their strategy lies in extracting and acting upon the right data.

Walking through the mRNA manufacturing process – and its many challenges.

Widely-used antimalarial drugs are losing efficacy. What are researchers doing to prevent that?

How critical anti-cancer drugs can be sustainably developed from genetically engineered baker’s yeast.

Voting is now open for the 2023 Company of the Year Awards – make sure you have your say!

AI’s role in pharma operations and process is growing. But does it have the power to transform the industry?

Exploring the potential of self-amplifying RNA and circular RNA in the future of drug development.